Salivary gland cancers

What changed: Salivary gland cancers

Cancer page →

Every dated change on the records linked to Salivary gland cancers, newest first: approvals and regulatory steps on its medicines, trials that reported, guideline versions, milestones, and when this page itself was checked. Dates come from the records; none is inferred. Orientation, not medical advice.

Guideline1Milestone8This record1

FollowWatch this cancer and Saved shows what changed since you last looked.Follow by feed

September 2026 · 1

2026-09-08This recordSalivary gland cancers
Facts on this page last checked
When this page itself was last checked or edited.

2022 · 2

2019 · 1

2019MilestoneTrastuzumab
Trastuzumab-docetaxel in HER2+ salivary duct carcinoma (Takahashi, JCO); lenvatinib in ACC (Tchekmedyian, JCO)
A milestone in how this cancer is treated.

2018 · 1

2018MilestoneLarotrectinib
Larotrectinib approved tumour-agnostically, including secretory carcinoma
A milestone in how this cancer is treated.

2010 · 1

2010MilestoneNTRK
Mammary analogue secretory carcinoma with ETV6-NTRK3 described (Skálová)
A milestone in how this cancer is treated.

2009 · 1

2009MilestoneSalivary gland cancers
MYB-NFIB fusion in adenoid cystic carcinoma (Persson, PNAS)
A milestone in how this cancer is treated.

2003 · 1

2003MilestoneGene fusion
CRTC1-MAML2 fusion in mucoepidermoid carcinoma (Tonon)
A milestone in how this cancer is treated.

1994 · 1

1994MilestoneSalivary gland cancers
Neutron therapy trial (RTOG-MRC) in unresectable salivary cancer
A milestone in how this cancer is treated.

1859 · 1

1859MilestoneSalivary gland cancers
Billroth describes 'cylindroma' (adenoid cystic carcinoma)
A milestone in how this cancer is treated.